04:30 PM EDT, 07/01/2024 (MT Newswires) -- Y-mAbs Therapeutics ( YMAB ) appointed Peter Pfreundschuh as chief financial officer, effective June 28.
Pfreundschuh, 55, previously served as CFO at Voyager Therapeutics, Y-mAbs Therapeutics ( YMAB ) said Monday in a regulatory filing. He succeeds Bo Kruse.